Back to search

Cediranib (AZD2171) for the treatment of recurrent small cell lung cancer (SCLC): A California Consortium phase II study (NCI # 7097)

Suresh S. Ramalingam, Philip C. Mack, Everett E. Vokes, Jeff Longmate, Ramaswamy Govindan
DOI: 10.1200/jco.2008.26.15_suppl.8078
Journal of Clinical Oncology

Data up to Jan 2025

Published2008
Citations26
References0
Fields
MedicineInternal medicineGastroenterologyOncology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Cediranib (AZD2171) for the treatment of recurrent small cell lung cancer (SCLC): A… (2008) – Journal of Clinical Oncology | Metascience Observatory Explorer